You are here

Slimina weightloss capsules

Safety advisory

18 August 2011

The Therapeutic Goods Administration (TGA) is aware that some Australian consumers may have purchased the product Slimina weightloss capsules over the internet. The label of this product claims the ingredients to be 100% herbal in origin.

However, analysis undertaken by the TGA Laboratories in Australia has confirmed the presence of therapeutic quantities of sibutramine in these capsules. Consumers are advised that sibutramine was a prescription-only medicine supplied in Australia until it was withdrawn in October 2010 due to safety concerns, particularly in patients with history of cardiovascular disease.

Slimina weightloss capsules have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA. In Australia, commercial supply of Slimina weightloss capsules is illegal.

If you have purchased Slimina weightloss capsules you are advised to cease using them and discard any remaining product. If you have concerns arising from your use of this product, you should consult your health care practitioner.

Consumers are again advised to exercise extreme caution about purchasing medicines from unknown overseas internet sites. Products purchased in this way may not meet the same standards of quality, safety and efficacy as those approved by the TGA for supply in Australia, and may contain undisclosed and potentially harmful ingredients.

Slimina weightloss packagingSlimina weightloss capsules